BONESUPPORT® Announces Availability in Europe of CERAMENT™|G in 5 mL Volume to Address Growing Market Demand

20th October 2020

BONESUPPORT™ Announces Nature Publication of Pre-Clinical Study Highlighting CERAMENT®’s Attractive Bone Remodeling Properties and as a Local Drug Delivery Platform for Bone Disease

20th October 2020

BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study

20th October 2020

BONESUPPORT™‘s CERAMENT®|G and CERAMENT® V to be Featured Extensively at the 35th Annual Meeting of the European Bone & Joint Infection Society (EBJIS) in Oxford, UK

20th October 2020

BONESUPPORT™‘s CERAMENT®|G Highly Effective Adjunct in the Single Stage Surgical Management of Chronic Osteomyelitis

20th October 2020

BONESUPPORT™ Announces Key Corporate Appointment To Drive Growth in North America

20th October 2020

Richard Davies Wins “Best CEO in the Biomaterials Industry” Award from European CEO Magazine

20th October 2020

BONESUPPORT™ – First Patient Recruited in Study Evaluating CERAMENT® G and CERAMENT® V in Patients Undergoing Hip and Knee Arthroplasty Revisions

20th October 2020

BONESUPPORT™ – CERAMENT® G’s POTENTIAL TO PREVENT AND MANAGE BIOFILM-RELATED BONE INFECTIONS HIGHLIGHTED IN NEW HIGH-PROFILE PUBLICATION

20th October 2020

BONESUPPORT™ SIGNS COMMERCIALIZATION AGREEMENT FOR THE ITALIAN MARKET

20th October 2020